Diagnostyka

Diagnostyka PEG

The PEG Ratio (Price/Earnings-to-Growth) of Diagnostyka (DIA.WA) as of Oct 30, 2026 is 1.68. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 1.90 — a change of -11.24% (lower).

PEG

1.68

YoY

-11.24%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Diagnostyka is 2025 1.68 . PEG Ratio (Price/Earnings-to-Growth) of Diagnostyka was 2024 1.90 . It decreases by -11.24% lower compared to the previous year.

The Diagnostyka PEG history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PEG
Date
PEG
Jan 1, 2021
0.76 PLN
Jan 1, 2022
2.53 PLN
Jan 1, 2023
3.43 PLN
Jan 1, 2024
1.90 PLN
Jan 1, 2025
1.68 PLN
The Diagnostyka PEG history
YEARPEGYoY
1.68-11.24%
1.90-44.73%
3.43+35.64%
2.53+233.18%
0.76—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Diagnostyka Stock analysis

What does Diagnostyka do? Diagnostyka SA generates revenue through its network of 180 laboratories and 1,100 Sampling Labs across Poland, offering over 3,000 test types including hematology, infection diagnostics, allergology, and hormonal diagnostics. The company provides both routine and specialist laboratory services, with tests available with or without a physician's referral, catering to individual patients and healthcare providers. Its specialization in molecular biology, autoimmune diagnostics, and blood collection drives demand from private individuals seeking direct access to medical analysis without a doctor's prescription. The firm's revenue model relies on a comprehensive service chain from biological material collection and transportation to final analysis results, serving a broad customer base including patients, clinics, and hospitals. With a focus on accessible diagnostics, Diagnostyka SA expands its market reach through its extensive lab network, enabling widespread availability of medical testing services throughout Poland. The company's ability to deliver specialized tests like molecular biology and autoimmune diagnostics differentiates its offerings in the healthcare sector. Diagnostyka is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Diagnostyka stock

PEG Ratio (Price/Earnings-to-Growth) of Diagnostyka is 1.68 in 2025.

PEG Ratio (Price/Earnings-to-Growth) of Diagnostyka changed from 1.90 to 1.68, representing a -11.24% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Diagnostyka since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Diagnostyka with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Diagnostyka

All Key Metrics — Diagnostyka